Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5338300

Cc1ccc(NC(=O)Nc2nc(C[As](C)C(C)C)cs2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.48
▸ MEN1 O00255 5/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ ALDH1A1 P00352 5/20 0.47
▸ CYP1A2 P05177 3/20 0.47
▸ CYP2C9 P11712 3/20 0.47
▸ CYP2C19 P33261 3/20 0.47
▸ LMNA P02545 3/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ POLB P06746 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ ITGB1 P05556 3/20 0.41
▸ ITGA4 P13612 3/20 0.41
▸ HTT P42858 1/20 0.39
▸ ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5359387 0.82 MAPT (0.50) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5338303 0.74 ALDH1A1 (0.34) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5218299 0.73 MAPT (0.53) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14014120 0.69 RAB9A (0.80) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5214312 0.68 MAPT (0.50) MAPTMEN1KMT2ALMNATP53
SCHEMBL10084544 0.67 LMNA (0.71) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL1514657 0.67 LMNA (0.67) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL17935540 0.65 LMNA (0.57) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL17925431 0.65 MAPT (0.47) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL13234810 0.64 NPC1 (0.69) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809380-A2 INHIBITORS OF HIV-1 CAPSID FORMATION: SUBSTITUTED ARYL AMINOMETHYL THIAZOLE UREAS AND ANALOGUES THEREOF Achillion Pharmaceuticals, Inc. (US) 2007-07-25 — — EP claimed
WO-2006053323-A2 INHIBITORS OF HIV-1 CAPSID FORMATION: SUBSTITUTED ARYL AMINOMETHYL THIAZOLE UREAS AND ANALOGUES THEREOF ACHILLION PHARMACEUTICALS, INC. (US) 2006-05-18 — — WO claimed
Send feedback